This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Inke, S.a.. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Barcelona, ES (2010)
- Agramunt, ES (2012)
Company Filing History:
Years Active: 2010-2012
Title: Innovations of Reyes Herbera Espinal
Introduction
Reyes Herbera Espinal is a notable inventor based in Agramunt, Spain. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative approaches to drug formulation and preparation. With a total of three patents to his name, Espinal's work showcases his dedication to advancing medical science.
Latest Patents
Espinal's latest patents include a polymorphic form of Granisetron base, methods for obtaining it, and formulations containing it. This invention relates to a new polymorphic form of Granisetron base, known as Form I. The patent details methods for obtaining this form, including the use of various solvents such as hexane, acetone, toluene, diethyl ether, 2-propanol, tetrahydrofuran, and acetonitrile. Additionally, he has developed a method for preparing a mixed solvate of olanzapine, characterized by the methylation of N-desmethylolanzapine with dimethyl sulfate, utilizing tetrahydrofuran and water as solvents.
Career Highlights
Espinal's career is marked by his innovative contributions to pharmaceutical formulations. His work has not only advanced the understanding of drug solvation but has also provided new methods for preparing essential medications. His patents reflect a commitment to improving drug efficacy and safety.
Collaborations
Espinal has collaborated with notable colleagues in his field, including Pere Dalmases Barjoan and Salvador Puig Torres. These collaborations have likely enriched his research and contributed to the success of his inventions.
Conclusion
Reyes Herbera Espinal is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in drug formulation. His innovative patents demonstrate his expertise and commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile